Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 5 institutions in 3 countries.
Alice AtramontCaisse Nationale de l'Assurance Maladie, Paris, France.
Guillaume L MartinCaisse Nationale de l'Assurance Maladie, Paris, France.
Mervyn SingerBloomsbury Institute for Intensive Care Medicine, Division of Medicine, University College London, London, United Kingdom.ORCID 0000-0002-1042-6350
Ayden TajahmadyCaisse Nationale de l'Assurance Maladie, Paris, France.
Emin AgamaliyevCaisse Nationale de l'Assurance Maladie, Paris, France.
Michael O HarhayClinical Trials Methods and Outcomes Lab, PAIR (Palliative and Advanced Illness Research) Center & Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-0553-674X
Marc LeoneDepartment of Anesthesia and Intensive Care Unit, Assistance Publique Hôpitaux de Marseille, Hospital Nord, Aix-Marseille University, Marseille, France.
Matthieu LegrandDivision of Critical Care Medicine, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, California; and.ORCID 0000-0001-9788-5316
l'Assurance Maladie · FRAix-Marseille Université · FRBury College · GBUniversity of California, San Francisco · USUniversity of Pennsylvania · US
Funding
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical toolsR01HL168202 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Michael Oscar Harhay, Fan Li · 2023 to 2026
$2.9M
Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURNR01GM151494 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthieu Legrand · 2023 to 2026
$1.5M
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failureR00HL141678 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2020 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
One-Year Survival and Hospital-free Days in Critical Illness After Viral Pneumonia. · full record | OpenQuestion